米国のCOPD（慢性閉塞性肺疾患）市場

U.S. COPD Market - Therapeutic Overview and Patient Outlook

発行	Frost & Sullivan
出版日	2007年06月	商品コード	52899
ページ情報	英文 80 Pages
価格	US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License) US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)

概要
原文目次
関連レポート

原文目次

Abstract

This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.

1 EXECUTIVE SUMMARY

Executive Summary
- Introduction

2 TOTAL MARKET

Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Disease Definition
- Symptoms
- Risk Factors
- Diagnosis
- Treatments
- Drug Delivery Methods
- Disease Statistics
- Competitive Structure
Patient Outlook
- Patient Forecasts
General Market Trends
- Challenges
- Strategic Recommendations for Challenges
- Market Drivers
- Market Restraints

3 MARKETED THERAPIES OVERVIEW

Overview
- Bronchodilators
- Anti-inflammatories
- Combination Therapies
- Novel Therapeutic Approaches

4 APPENDIX

Decision Support Databases
- Chronic Obstructive Pulmonary Disease Population
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Population 65 and Over
- Prevalence of Asthma